Author

Rostislava Angelova

Institution: Medical University of Sofia

Observed institution: Medical University of Sofia

ORCID: 0009-0003-3815-6043

Observed ORCID: 0009-0003-3815-6043

OpenAlex ID: A5012700330

Ferrocene modified analogues of imatinib and nilotinib as potent anti-cancer agents

2023 · Irena Philipova, Rositsa Mihaylova, et al. · RSC Medicinal Chemistry · 14

Ferrocene Derivatives as Histone Deacetylase Inhibitors: Synthesis and Biological Evaluation

2025 · Rostislava Angelova, Georgi Stavrakov · Organics · 6

Non-Classical Binding Mechanisms of Ferrocene-Modified Imatinib and Nilotinib Analogues in BCR-ABL1 Kinase Revealed by Computational Analysis

2026 · Rostislava Angelova, Georgi Stavrakov, et al. · Molecules · 1

Oncopharmacological aspects of Bcr-Abl inhibitors: from revolutionary structure-based design to clinical resistance

2026 · Rostislava Angelova, Georgi Momekov, et al. · Pharmacia

Works count: 4

Citation count: 21

H-index: 2

I10-index: 1